Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio

Annals of Hematology

Volumn 93, Issue 5, 2014, Pages 841-846

  Kelkitli, Engin ^a   Atay, Hilmi ^b   Çilingir, Fatih ^c   Güler, Nil ^c   Terzi, Yüksel ^c   Özatlı, Düzgün ^c   Turgut, Mehmet ^c  

^a Erzurum State Research and Training Hospital   (Turkey)

^b Van Training and Research Hospital ^*  (Turkey)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Multiple myeloma; Neutrophil lymphocyte ratio; Prognostic factor; Survival

Indexed keywords

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BONE MARROW; BRAIN HEMORRHAGE; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HEART FAILURE; HEART TAMPONADE; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; LUNG EMBOLISM; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUTROPHIL; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PLASMA CELL; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; TETRAPLOIDY; TRISOMY; TRISOMY 11;

ADULT; AGED; BLOOD CELL COUNT; CASE-CONTROL STUDIES; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL ANALYSIS;

EID: 84898927162     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1978-8     Document Type: Article

References (19)

1. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J et al (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412-3420
2. Wuilleme S, Robillard N, Lodé L, Magrangeas F, Beris H, Harousseau JL et al (2005) Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma. Leukemia 19:275-278
3. Zahorec R (2001) Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102:5-14
4. Mohri Y, Tanaka K, Ohi M, Yokoe T, Miki C, Kusunoki M (2010) Prognostic significance of host- and-tumor-related factors in patients with gastric cancer. World J Surg 34:285-290
5. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181-184
6. Halazun K, Hardy MA, Rana AA, Woodland DC, Luyten EJ, Mahadev S et al (2009) Negative impact of neutrophil/lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 250:141-151
7. Porrata LF, Ristow K, Habermann T, Inwards DJ, Micallef IN, Markovic SN (2010) Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio. Am J Hematol 85:896-899
8. Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K et al (2006) International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia 20:1467-1473
9. Blade J, Rosinol L, Cibeira MT (2008) Prognostic factors for multiple myeloma in the era of novel agents. Ann Oncol 7:117-120
10. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137:425-428
11. Schmidt H, Suciu S, Punt CJ, Gore M, Kruit W, Patel P et al (2007) Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol 25:1562-1569
12. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867
13. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539-545
14. Liu H, Tabuchi T, Takemura A, Kasuqa T, Motohashi G, Hiraishi K et al (2008) The granulocyte/lymphocyte ratio as an independent predictor of tumor growth, metastasis and progression: its clinical applications. Mol Med Rep 1:699-704
15. Wang S, Zhang Z, Fang F, Gao X, Sun W, Liu H (2011) The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett 2:735-740
16. McMillan DC, Canna K, McArdle CS (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90:215-219
17. Bataille R, Boccadoro M, Klein B, Durie B, Pileri A (1992) C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood 80:733-737
18. Kleber M, Ihorst G, Descheler B, Jakob C, Liebisch P, Koch B et al (2009) Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients. Eur J Haematol 83:519-527
19. Andrew D, Giampaolo M (2012) Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities. Nephrol Dial Transplant 27:3713-3718